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In Brief
The role of surface loops in encoding SH2 domain specificity
has been systematically investigated by characterizing a group
of loop variants obtained from
screening phage-displayed SH2
domain libraries. The reported
results support a general role for
the EF loop (which connects the
␤-strands E and F) and the BG
loop (which connects the ␣-helix
B and ␤-strand G) in encoding
SH2 specificity, add to our understanding of the mechanism of
target sequence recognition by
an SH2 domain in cells, and
have general implications for the
evolution of binding specificity of
protein interaction modules.

Highlights
• Surface loops play an essential role in SH2 domain specificity.
• Diverse specificities may be obtained from a single SH2 domain by combinatorial mutations in the EF
and BG loops.
• The specificity of a loop mutant correlates with the sequence characteristics of the bait peptide used
in its isolation.
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Surface Loops in a Single SH2 Domain Are
Capable of Encoding the Spectrum of
Specificity of the SH2 Family*□
S

Huadong Liu‡§, Haiming Huang¶, Courtney Voss§, Tomonori Kaneko§,
Wen Tao Qin§, Sachdev Sidhu¶储, and Shawn S.-C. Li§**
Src homology 2 (SH2) domains play an essential role in
cellular signal transduction by binding to proteins phosphorylated on Tyr residue. Although Tyr phosphorylation
(pY) is a prerequisite for binding for essentially all SH2
domains characterized to date, different SH2 domains
prefer specific sequence motifs C-terminal to the pY residue. Because all SH2 domains adopt the same structural
fold, it is not well understood how different SH2 domains
have acquired the ability to recognize distinct sequence
motifs. We have shown previously that the EF and BG
loops that connect the secondary structure elements on
an SH2 domain dictate its specificity. In this study, we
investigated if these surface loops could be engineered to
encode diverse specificities. By characterizing a group of
SH2 variants selected by different pY peptides from
phage-displayed libraries, we show that the EF and BG
loops of the Fyn SH2 domain can encode a wide spectrum
of specificities, including all three major specificity
classes (p ⴙ 2, p ⴙ 3 and p ⴙ 4) of the SH2 domain family.
Furthermore, we found that the specificity of a given variant
correlates with the sequence feature of the bait peptide
used for its isolation, suggesting that an SH2 domain may
acquire specificity by co-evolving with its ligand. Intriguingly, we found that the SH2 variants can employ a variety of
different mechanisms to confer the same specificity, suggesting the EF and BG loops are highly flexible and adaptable. Our work provides a plausible mechanism for the SH2
domain to acquire the wide spectrum of specificity observed in nature through loop variation with minimal disturbance to the SH2 fold. It is likely that similar mechanisms
may have been employed by other modular interaction domains to generate diversity in specificity. Molecular &
Cellular Proteomics 18: 372–382, 2019. DOI: 10.1074/mcp.
RA118.001123.

The Src homology 2 (SH2)1 domain, originally identified in
the viral oncogene product v-fps/fes, was subsequently

found in numerous metazoan proteins (1, 2). It is known
now that the human genome encodes ⬃120 SH2 domains
that are dispersed in more than 110 proteins. These include protein or lipid kinases, protein phosphatases, small
GTPases, cytoskeleton regulators, and adaptor/scaffolding
proteins and other regulators of signal transduction (3– 4).
SH2 domains exert their functions by binding to the phosphotyrosine (pY) residue embedded in specific sequence
motifs, thereby enabling transduction of signals emanated
from tyrosine kinases to downstream molecules (1, 5, 6).
The importance of the tyrosine kinase-pY-SH2 signaling
axis in normal physiology and disease pathogenesis is underscored by the fact that drugs targeting components of
this axis form the largest collection of targeted therapeutics
used in the clinic to treat cancer and other complex human
diseases (7).
SH2 domains, related to one another by structure and
function, are ⬃100-residue in length and fold into a globular
structure comprising a central ␤-sheet (with strands ␤A to
␤G) flanked by two ␣-helices (␣A and ␣B) (8 –10). A typical
SH2 domain recognizes the pY and a specific residue Cterminal to the pY in a two-pronged plug two-holed socket
mode (11, 12). Although all SH2 domains contain a pYbinding pocket and share virtually the same mode of pY
recognition (8), they differ in specificity and mode of recognition for the C-terminal residue (3, 13). Based on results
from a systematic structure-function analysis, we categorized the mammalian SH2 domains into three specificity
classes, p ⫹ 2, p ⫹ 3 and p ⫹ 4 (13). The p ⫹ 3 class,
exemplified by the Src SH2 domain, prefers a hydrophobic
residue at the p ⫹ 3 position (the third residue C-terminal to
the pY residue). The Grb2 and BRDG1 SH2 domains, which
belong to the p ⫹ 2 and p ⫹ 4 classes respectively, prefer
peptides with an Asn at the p ⫹ 2 or a hydrophobic residue
at the p ⫹ 4 position (13–15).
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Surface Loops Encode SH2 Domain Specificity

FIG. 1. Directed evolution of the Fyn SH2 domain via systematic changes in the EF and BG loops. A, Structure of the FYN-SH2 domains
in complex with a tyrosine-phosphorylated peptide (PDB ID 4U1P). The bound peptide is colored magenta, with the side chains of pTyr and
p ⫹ 3 Ile residues shown as sticks. The p ⫹ 3 Ile is located between the EF and BG loops. Residues targeted for evolution via combinatorial
mutagenesis are identified with blue balls for the EF loop (EF1, EF2 and EF3) and red balls for the BG loop (BG2, BG3 and BG4). B, The phage
display library design. The three resides from the EF and BG loops targeted for mutagenesis were underscored in the sequence of the human
Fyn-SH2 domain. The length of both loops was unchanged in the 3 ⫹ 3 library, whereas the length of BG loop was varied in the 3⫹x library,
from two-residue shorter to three-residue longer, but not 3.

The C-terminal specificity is mediated by a binding pocket
or site—referred to herein as specificity pocket— on the surface of an SH2 domain that accommodate the p ⫹ 2, p ⫹ 3 or
p ⫹ 4 residue in the peptide ligand (13). We have shown
previously that two surface loops on the SH2 domain, namely
the EF loop (which connects the ␤-strands E and F) and the
BG loop (which connects the ␣-helix B and ␤-strand G), not
only participate in the formation of the specificity pockets, but
also control access of the peptide ligand to the pockets (14).
In a typical SH2 domain, only one of the three specificity
pockets is available for ligand binding whereas the remaining
pockets are made inaccessible because of pocket-plugging
or steric hindrance created by specific residues from the EF
and BG loops. For example, in the Src SH2 domain (p ⫹ 3
class), the p ⫹ 4 pocket is plugged by a residue from the BG
loop whereas in the BRDG1 SH2 domain (p ⫹ 4 class), the
p ⫹ 3 pocket is blocked by an EF loop residue. In the case of
the Grb2 SH2 domain (p ⫹ 2 class), both the p ⫹ 3 and p ⫹
4 binding pockets are blocked (13). The critical role of the EF
and BG loops in governing SH2 domain specificity was underscored in the observation that specificity of an SH2 domain may be altered, or even class-switched, by mutating key
residues within these loops. Of note, mutating the EF1 residue
in the Src SH2 domain from Thr to Trp resulted in switch of
specificity from the p ⫹ 3 to p ⫹ 2 class (16). In contrast,
substituting the EF2-Leu residue in the p ⫹ 4 class BRDG1
SH2 domain with an Ala caused a switch of specificity to the
p ⫹ 3 class (13).
Although the above studies suggest a pivotal role for the EF
and BG loops in SH2-ligand binding, they also raise an important question: can these surface loops encode the wide
spectrum of specificities found for the SH2 domain family in a
fashion akin to the role of the complementarity-determining
1

The abbreviations used are: SH2, Src homology 2; CDR, complementarity-determining loops; OPAL, oriented peptide array library.
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regions (CDR) in determining the specificity of an antibody
(17)? To address this question, we generated phage-displayed libraries of the Fyn SH2 domain in which the EF and
BG loops were randomized in length and residue composition. By screening the libraries with pY-peptides with diverse
sequences, we identified variants that exhibited a wide range
of specificities. Using peptide arrays, including Oriented Peptide Array Libraries (OPAL) and ligand peptide arrays, and
in-solution binding assays, we determined the specificity and
affinity for a panel of 29 variants isolated from the phagedisplayed library screening. Our data shows that the EF and
BG loops are highly evolvable and capable of encoding a wide
spectrum of specificity found in naturally occurring SH2
domains.
MATERIALS AND METHODS

Phage Display—The Fyn-SH2 EF/BG loop library was constructed
by Kunkel mutagenesis (8, 18). The library was panned against biotin-pY peptides immobilized on a Maxisorp plate (NUNC) precoated
with streptavidin. After four cycles of panning, enriched phage pools
were applied to infect E. coli XL1-Blue to obtain single colonies.
Phage ELISA was conducted by adding the single colony phage
solution into a 96-well Maxisorp plate (NUNC) precoated with streptavidin and biotin-pY peptides. Positive phages were subject to DNA
sequencing to identify the sequences of the corresponding SH2
variants (8).
Peptide Synthesis—Peptides were synthesized on the Tentagel
resin on an Intavis-AG MultiPep peptide synthesizer using Fmoc
(N-(9-fluorenyl)methoxycarbonyl) chemistry. Peptides were labeled,
at the N terminus, with either biotin for printing and pulldown assays
or fluorescein for binding studies by fluorescence polarization (8). A
spacer containing Ahx-Ahx-Ser-Gly-Gly (Ahx, 6-aminohexanoic acid)
was inserted between the biotin or fluorescein and the peptide to
minimize the effect of labeling. Purity and identities of the peptides
were verified by mass spectrometry.
Peptide Array Slide Preparation and Probing—Biotin-labeled peptides were incubated in PBS (phosphate buffered saline), pH 7.5 with
neutravidin in a 1:1 molar ratio for 1h at room temperature. The
mixture was diluted in PBS to 25 M. SuperAB glass slides (Fisher,
Pittsburgh, PA) were preactivated in 50 mM NaIO4, 0.1 M sodium
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acetate, pH 5.5 for 0.5h at room temperature, dried with nitrogen
stream and used immediately. The peptide-neutravidin conjugates
were printed onto an activated SuperAB chip (Fisher) using a Bio-Rad
VersArray Chipwriter-Pro system. Before probing with a purified SH2
protein, the peptide array chip was washed three times in 3% BSA in
TBST buffer (0.1 M Tris-HCl, pH 7.4, 150 mM NaCl, and 0.1% Tween
20). For probing, 1.0 M total GST-SH2 protein was added directly to
the 3%BSA/TBST buffer and incubated with the slide for 1h at RT.
The slide was then washed three times in TBST and incubated with a
rabbit anti-GST antibody (Abcam, Toronto, ON, Canada #ab3416).
After 1h, the slide was washed 3X in TBST and incubated with a
DyLight 649-labeled goat anti-rabbit IgG antibody (Pierce, Pittsburgh,
PA #35565) for 1 h in the dark. The slide was washed again in TBST,
dried in the dark, and scanned with a microarray laser scanner (Tecan
Co., Männedorf, Switzerland). Data processing and quantification
were performed using the embedded software of the scanner.
Array Data Analysis—Data processing and quantification were performed using the embedded software of the scanner. The binding
signal for a variant was calculated as the average value of the quadruple repeats for each peptide. Then, the binding signals were normalized across the entire array.
The selectivity score (z-score) of a variant domain for each pY
peptide is defined according to the formula

冉

Z ⫽ Bi ⫺

1
n

冘冊
n

Bi /

1

Where Bi is the average signal of binding,  is the standard deviation of Bi. If more than one residue in the position was considered,
the average of Z score for each amino acid was used.
Fluorescence Polarization Measurements—Each SH2 protein was
serially diluted in a 384-well plate, followed by the addition of fluorescein-labeled peptide in PBS buffer. The mixtures were incubated in
the dark for 30 min prior to fluorescent polarization measurements at
RT on an EnVision Multilabel Plate Reader (PerkinElmer) with the
excitation set at 480 nm and emission at 535 nm. Binding curves were
generated by fitting the binding data to a hyperbolic nonlinear regression model using Prism 3.0 (GraphPad software, Inc., San Diego, CA),
which also produced the corresponding dissociation constants (Kd).
RESULTS

The EF and BG Loops Are Highly Evolvable—We employed
the Fyn SH2 domain to test if the EF and BG loops can
encode a wide range of specificity. The EF loop of the Fyn
SH2 domain comprises three residues (i.e. TTR) whereas its
BG loop seven residues (i.e. AAGLSSR). We generated two
libraries of the Fyn SH2 domain in which the EF and BG loop
residues were randomized by Kunkel mutagenesis (8, 18)
(Fig. 1). The resulting libraries were displayed, respectively,
on the M13 bacteriophage and screened for binding to
immobilized pY peptides (8) representing the three major
ligand classes (i.e. p ⫹ 2N, p ⫹ 3, and p ⫹ 4). The library
screens led to the isolation of 152 unique variants (supplemental Table S1) bound by 19 bait peptides (supplemental
Table S1). Based on sequence diversity of the bait peptides

and the isolated variants, we selected 29 Fyn SH2 variants
for further analysis (Fig. 2).
A noteworthy feature of the variants selected by the p ⫹ 2N
group of bait peptides (Fig. 2A) is the enrichment for aromatic
residues within the EF loop. Indeed, 33 of the identified clones
contained an aromatic residue (W, Y or F) at the EF1 position.
A bulky, aromatic EF1 residue would likely block the pY⫹3
binding pocket in a manner like the EF1-Trp residue in the
Grb2 SH2 domain (p ⫹ 2 class) (13). To encode p ⫹ 2N
specificity, it is also necessary to have the p ⫹ 4 binding
pocket plugged. This appeared to be accomplished in most
cases by an amino acid with a long, aliphatic sidechain (L, V
or I) at the BG2 position, or in some instances, the BG4 or
BG3 position (Fig. 2A). Intriguingly, several variants (e.g. V10)
captured by the PDGFR␤-pY716 peptide (which contained
the small hydrophobic residue, Ala, at the p ⫹ 4 position in
addition to an Asn at p ⫹ 2) contained a truncated BG loop in
which the residues BG2–BG4 or BG3–BG4 were missing.
In the same vein, selection by the L4 peptide (p ⫹ 4Leu, Fig.
2B and Table I) yielded four variants (including V17) with the
BG loop either completely missing or drastically curtailed. As
a shortened BG loop would leave the p ⫹ 4 binding pocket
unblocked, these mutants are expected to have acquired p ⫹
4 specificity (vide infra). As shown later (Table I), V17, but not
V10, exhibited a stronger preference for the p ⫹ 4L peptide. In
contrast, most variants selected by the p ⫹ 3Ile (I3) peptide
featured a Leu or an Ile residue at the BG2 or BG4 position
and a non-aromatic residue at the EF1 position, suggesting
that these variants have retained the p ⫹ 3 specificity of the
wild-type (wt) Fyn SH2 domain.
Characterization of SH2 Variant Specificity by OPAL—To
survey the breadth of new specificities, we selected 29 Fyn
SH2 variants with distinct EF/BG loop characteristics (Fig. 2)
and expressed them respectively in E. coli as GST fusion
(supplemental Fig. S1). The purified GST-SH2 protein was
then used to screen an Oriented Peptide Array Library (OPAL)
containing the degenerated sequence x-pY-x-x-x-x-x (where
x denotes a mixture of 19 natural amino acids excluding Cys)
(19). We have previously employed the OPAL approach to
characterize the specificity of human SH2 domains (3). A
notable difference between the current and previous methods
(3) is that the current OPAL sublibraries were labeled with
biotin and printed onto neutravidin-coated glass slides instead of being spotted on cellulose membranes. Moreover,
each sublibrary was printed in quadruplicates to control printing quality (supplemental Fig. S2).
A rabbit anti-GST antibody was used as the primary antibody and a goat anti-rabbit IgG labeled with DyLight-649 as
the secondary antibody to visualize the bound GST fusion

FIG. 2. Loop sequences of the variants identified by different bait peptides. Residues in the bait peptide and EF/BG loop sequences are
colored according to their chemical nature. The 29 variants selected for subcloning and further characterization are annotated with the variant
numbers. A, Variants identified by bait peptides containing the pY⫹2N motif. B, Variants identified by bait peptides that contain a hydrophobic
residue at either the pY⫹3 or pY⫹4 position.

Molecular & Cellular Proteomics 18.2

375

376

Notes: Dissociation constants (Kd, in M, ⫾standard deviation) are derived from fluorescein polarization measurements (see also supplemental Fig. S7A–S7K). NB, no binding or
binding too weak to determine the Kd of. All peptides were synthesized with an N-terminal spacer containing the sequence fluorescein-Ahx-Ahx-Ser-Gly-Gly, where Ahx denotes
6-aminohexanoic acid.

0.3 ⫾ 0.06 (8.3) 1.3 ⫾ 0.57 1.0 ⫾ 0.18 (2.5)
6.3 ⫾ 1.77 (0.6) 14.4 ⫾ 2.66 1.0 ⫾ 0.13 (2.5)
NB
4.1 ⫾ 0.51
NB
2.5 ⫾ 0.46 4.2 ⫾ 1.04

2.8 ⫾ 0.33 (2.3) 6.3 ⫾ 0.71 2.1 ⫾ 0.29 (3.1)
4.8 ⫾ 1.10 3.6 ⫾ 0.52 (1.8)
6.5 ⫾ 1.36 5.0 ⫾ 1.43 10.6 ⫾ 2.84 27.2 ⫾ 13.93 2.3 ⫾ 0.38 23.7 ⫾ 3.36 (0.2)

4.1 ⫾ 0.47 (0.1) 1.0 ⫾ 0.26 0.5 ⫾ 0.11 (1.2)
4.9 ⫾ 1.08 (0.1) 19.9 ⫾ 4.54 0.1 ⫾ 0.02 (6)
NB
NB
0.6 ⫾ 0.08 0.7 ⫾ 0.13

NB

7.3 ⫾ 2.66 4.2 ⫾ 0.72 (1.3) 24.5 ⫾ 5.00 (0.2) 6.8 ⫾ 1.14 0.3 ⫾ 0.04 (19)
1.7 ⫾ 0.28 (3.3)
6.3 ⫾ 0.86
0.4 ⫾ 0.09
5.7 ⫾ 1.36 4.5 ⫾ 1.56

NB

2.5 ⫾ 0.29 (0.3) 0.7 ⫾ 0.21 0.2 ⫾ 0.08 (3.5)
1.8 ⫾ 0.48 0.3 ⫾ 0.07 (2.3)
0.1 ⫾ 0.097 (7)
0.8 ⫾ 0.23
NB
0.8 ⫾ 0.25
0.7 ⫾ 0.15 1.7 ⫾ 0.34

EPQpYENEEE
(N2, p ⫹ 2N)
QPEpYVNQADV
(ErbB2-pY1139,
p ⫹ 2N)
EPQpYEEIEE
(I3, p ⫹ 3I)
NPDpYQQDFFP
(EGFR-pY1172,
p ⫹ 4)
EPQpYEEELE
(L4, p ⫹ 4L)

V18
V17
V14
V10
V8
V7
BRDG1
Grb2
Src
Fyn
Peptide (Specificity
Motif)

TABLE I
Dissociation constants and relative affinities (brackets) of a panel of Fyn SH2 variants for phosphopeptides representing different specificity classes
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protein by far-Western. The printing buffer (red rectangle, Fig.
3A) and GST (green rectangle) were included in the OPAL
slide as negative and positive controls, respectively. As
shown in Fig. 3A and supplemental Fig. S3A–S3C, each variant produced a unique binding pattern on the OPAL array.
For example, variant 6 (V6) showed a strong preference for an
Asn (N) at the p ⫹ 2 position, suggesting that it belongs to the
p ⫹ 2N class (Fig. 2A). The binding signals on an OPAL slide
were subsequently quantified and the intensity of each spot
was normalized against the average signal over the entire
slide to derive a Z-score indicative of preference for a given
amino acid residue at a specific position (Fig. 3B and supplemental Fig. S4A–S4F). This allowed for comparison of specificities for the different variants based on the corresponding Z
scores on the OPAL. As shown in Fig. 3B, the variants V1, V5,
V6, V8, and V11, which were selected by the p ⫹ 2N group of
peptides, indeed strongly preferred an Asn residue at the p ⫹
2 position. Exceptions were noted for a small number of
variants (e.g. V10) that did not show p ⫹ 2N specificity, likely
because of truncation in the BG loop (Fig. 2A). Interestingly,
V19, isolated by the pYEEEL (L4) peptide, displayed a strong
p ⫹ 2N selectivity. The presence of the EF1-Phe (to block the
p ⫹ 3 pocket) and BG2-Leu (to plug the p ⫹ 4 pocket) makes
V19 an ideal candidate for the p ⫹ 2N class.
The OPAL analysis indicates that the specificities of the bait
peptide and the isolated variants are closely related (Fig. 4A).
To facilitate analysis, we set 1.0 as the minimum Z score
required for a variant to qualify for a specificity class. Based
on this criterium, 82% (9/11) of the variants selected by peptides containing the pYxN motif could be assigned to the p ⫹
2N class. In contrast, only 50% (9/18) of the variants captured
by bait peptides without this motif could be assigned to the
p ⫹ 2N class by OPAL. Similarly, the percentage of variants
with the p ⫹ 3 specificity increased from 12% (2/17) to 50%
when the bait peptides contained the pYxx[I/L/V] motif. Based
on the corresponding Z scores for p ⫹ 2N and p ⫹ 3[I/V/L], we
clustered the variants into four groups (I-IV). Group II variants,
to which V6, V11, V8, and V1 belonged, exhibited greater
specificity for p ⫹ 2N than p ⫹ 3[I/L/V]. These variants were all
selected by peptides containing the pYxN motif. In contrast,
Group IV variants, composed of V24, V14, V26 and V23 and
selected by the pYxx[I/V/L] motif-containing peptides, had the
opposite specificity preference to the previous group. Intriguingly, the Group I variants V27, V29, V21, and V20 (selected by
bait peptides with no apparent motif) and the Fyn and p85␣-N
terminal (PI3K regulatory subunit) SH2 domains showed moderate specificity for both p ⫹ 2N and p ⫹ 3[I/L/V] (Fig. 4B).
Group III variants, on the contrary, displayed a low propensity
of binding to peptides with either the pYxN or pYxx[I/L/V]
motif. Together, these data suggest that the EF/BG loops in
the Fyn SH2 domain can evolve a wide spectrum of specificities that match grossly those of the bait peptides.
Determination of Variant Specificity by Ligand Peptide Array—To complement the OPAL assay, we determined the
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FIG. 3. Specificity of SH2 loop variants revealed by OPAL. A, A representative OPAL binding profile for the variant
V6. Each sublibrary was printed in quadruplicate (marked by a square). Neutravidin was included as the negative control (marked by red rectangle). GST was
employed as positive control (for GST
fusion proteins used to probe the OPAL)
and identified by a green rectangle. The
Fyn-SH2 variant V6 showed p ⫹ 2N
specificity. B, A heat map to show the
preference of the 29 variants for residues
at the p ⫹ 2 position. The Fyn, BRDG1
and PI3K-p85␣ SH2 domains were included as controls. The heat map was
generated using the corresponding Zscores on the OPAL.

specificity of the loop variants by peptide ligand array. The
same phosphopeptides used in the SH2 library screening
were individually synthesized, purified and printed onto a
glass slide. The resulting peptide ligand array was probed for
binding to different variants (supplemental Fig. S5A and S5B).
The binding signals were quantified and normalized to generate the corresponding Z score in the same manner as for the
OPAL data. We found that, on average, the larger the Z score,
the higher the affinity for a variant-ligand peptide pair (supplemental Fig. S6). Consistent with the OPAL results, the SH2
variants formed distinct clusters with the bait peptides containing the pYxN or pYxx[I/L/V] motif in the heat maps generated from the corresponding Z scores (Fig. 5). For example,
the majority of the Group II and some of the Group I variants
(Fig. 4B), including V1– 8, V11, V12, V15, V16, and V28, clustered with the pYxN peptides (Fig. 5, rectangle a). In contrast,

Molecular & Cellular Proteomics 18.2

the Group IV variants and some of the Group I variants (Fig.
4B), including V14, V20, V21, V23, V24, V26, V27, and V29,
showed a stronger preference for the pYxx[I/L/V] peptides
than the pYxN peptides (Fig. 5, rectangle b). Intriguingly, the
Fyn and p85␣ SH2 domains bound to both types of ligands,
suggesting that these naturally occurring SH2 domains have
broad specificities.
Specificity-determining Residues in the EF and BG Loops—
The OPAL-derived Z scores allowed us to rank the 29 variants
for proclivity to bind the pYxN, pYxx, or pYxxx motif. In
turn, this enabled us to identify residues within the EF and BG
loops that likely play an important role in conferring specificity
(13). For the p ⫹ 2 class of SH2 domain, it has been shown
that the peptide ligand must adopt a ␤-turn conformation to
avoid steric clash with the bulky EF1 residue (14). Indeed, we
found that the 7 variants with the strongest preference for the
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FIG. 4. Bait peptides affect specificity of the isolated loop variants. A, Pie
charts showing the number of variants
belonging to the specificity group p ⫹
2N or p ⫹ 3[I/L/V] based on the corresponding OPAL binding profiles. B, The
variants in (A) are divided into four
groups based on their Z scores.

pYxN motif (Z⬎2.0) contained a bulky aromatic residue (Trp,
Tyr or Phe) at the EF1 position (Fig. 6A). Furthermore, the
same variants contained an aliphatic residue (Ile, Leu, or Val)
at the BG2 position, which likely functions to plug the p ⫹ 4
binding pocket (Fig. 6A). Intriguingly, the next 11 variants that
ranked immediately after the above group with a moderate
p ⫹ 2N selectivity (with 1.0⬍Z⬍2.0) contained one or more
charged (R, K, D, or E) or hydrophilic (T, S, N, or Q) residues
within the EF loop. Curiously, the Fyn and p85␣ SH2 domains
also belonged to this group. It is possible that the charged or
hydrophilic residues in these variants facilitate the formation
of hydrogen bonds with the sidechain of the p ⫹ 2 Asn residue

378

or the backbone amide in the ligand peptide. Thus, the EF
loop may encode p ⫹ 2N specificity using a variety of different
mechanisms.
In contrast to the identification of numerous variants with
strong p ⫹ 2N selectivity, few variants showed a stronger
preference for the pYxx[I/V/L] motif than the Fyn SH2 domain
(Fig. 6B). This suggests that the wt Fyn SH2 domain is optimized for p ⫹ 3 binding. We noted that the 9 lowest ranked
variants for the p ⫹ 3[I/L/V] specificity all contained an aromatic residue at the EF1 position, suggesting that these variants would favor the pYxN motif. Indeed, 6 of these variants
(V6, V11, V8, V1, V5, and V7) were ranked with the strongest
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FIG. 5. Characterization of variant specificity by peptide ligand array. A heat map depicting the binding specificity of the loop variants
(top) for the different peptides (right) included in the ligand array. Rectangle “a” identifies variants with strong binding for pY⫹2N peptides, in
agreement with the OPAL data. Similarly, variants showing p ⫹ 3 [ILV] preference on the OPAL exhibited strong binding to peptides containing
these residues at pY⫹3 position (rectangle “b”).

p ⫹ 2N selectivity. Although the Fyn SH2 domain is not known
to possess p ⫹ 4 specificity, it showed a moderate preference
for bait peptides containing the pYxxx[L/F] motif. Intriguingly,
several variants, including V17 and V29, exhibited a greater
preference for this motif than the Fyn SH2 domain. As shown
below, the V17 and V29 variants bound to pYxxx[L/F] peptides with markedly greater affinities than the Fyn SH2 domain. Collectively, these data suggest that SH2 variants with
distinct specificities can be evolved through combinatorial
mutations in the EF and BG loops.
Identification of Variants with Distinct Specificities From the
Parent SH2 Domain—Although the OPAL and ligand peptide
arrays enabled us to identify variants with specificities that are
different from that of the parent domain, it is necessary to
confirm the predicted binding specificities/affinities in solution. To this end, we measured the dissociation constants of
several SH2 variants for peptides containing the pYxN, pYxx
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or pYxxx motifs by fluorescence polarization with purified
proteins and fluorescein-labeled peptides. We included the
Fyn SH2 domain for comparison and the Grb2, Src and
BRDG1 SH2 domains as representatives of the p ⫹ 2, p ⫹ 3,
and p ⫹ 4 specificity classes, respectively. The change in
affinity for a variant relative to the Fyn SH2 domain was used
as a measure of specificity toward the same peptide ligand.
In line with the peptide array results (Figs. 4 and 5), we
found that the Fyn SH2 domain was capable of binding to all
three types of peptides with submicromolar to micromolar
affinities (Table I, supplemental Fig. S6). However, the strongest affinity was observed for the I3 peptide, in agreement with
the Fyn SH2 domain belonging to the p ⫹ 3 specificity class.
Curiously, the Fyn SH2 domain bound much more tightly to
the N2 than the ErbB2-pY1139 peptide despite both containing the pYxN motif. Similarly, it displayed a significantly
greater affinity for the L4 than the EGFR-pY1172 peptide
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FIG. 6. The specificity defining residues in the loop variants. Ranking of variants for p ⫹ 2N (A), p ⫹ 3[I/V/L] (B) and p ⫹ 4[L/F] (C)
specificity based on the corresponding Z scores on OPAL.

FIG. 7. A cartoon model depicting the mechanism of p ⴙ 4 recognition by V17 (A) and p ⴙ 4 and p ⴙ 2N recognition by V29 (B, C).
The peptide ligand is shown in orange with specificity residues shown. Specificity-determining residues in the EF and BG loops are shown.

although both peptides contained a hydrophobic residue at
the p ⫹ 4 position (Table I). This suggests that the negatively
charged Glu residues in the N2, I3 and L4 peptides play a
significant role in binding the Fyn SH2 domain. Nevertheless,
because these three peptides differ only in the residue at the
p ⫹ 2, p ⫹ 3 or p ⫹ 4 position, they are ideal for gauging the
specificity changes for the variants.
Compared with the wt Fyn SH2 domain, the variant V8
displayed a 7-fold increase in affinity for the N2 peptide, but a
10-fold decreased affinity for the I3 peptide. This indicates
that V8, which showed a strong preference for an Asn at the
p ⫹ 2 position in the OPAL screen (Fig. 6A), has indeed
acquired a dominant p ⫹ 2N specificity. Similarly, variant
V14, which was predicted to possess a stronger p ⫹ 3[I/L/V]
specificity than Fyn SH2 domain (Fig. 6B) indeed showed
6-fold increased affinity for the I3 peptide. Variant V17,
which was predicted to prefer p ⫹ 4 over other specificity
(Fig. 6C), displayed 2– 8-fold increased affinity for the L4
(p ⫹ 4L) and EGFR-pY1172 (p ⫹ 4F) peptides and simultaneous 2.5–10-fold decreased affinity for the N2 and I3 peptides. This suggests that V17 has acquired a dominant p ⫹
4 specificity compared with the parent Fyn SH2 domain.

380

Because the BG loop in V17 is completely truncated, this
would leave the p ⫹ 4 pocket open for peptide binding (Fig.
7A). In comparison, variant V29, which was predicted to
have a greater preference for the p ⫹ 2N and p ⫹ 4[L/F]
motifs than the Fyn SH2 domain (Fig. 6), indeed showed
stronger binding to the corresponding peptides (Table I).
The EF1 position in V29 is occupied by a Trp, which could
be used to block the p ⫹ 3 binding pocket and thereby
engendering p ⫹ 2N specificity for the variant. Intriguingly,
the BG loop of V29 comprises a triad of bulky aromatic
residues (W-Y-W) that would not fit the p ⫹ 4 binding
pocket, thereby leaving the p ⫹ 4 pocket accessible for
ligand binding. Therefore, depending on the peptide, V29
may deploy either the p ⫹ 2N or p ⫹ 4 binding mode for
ligand recognition (Fig. 7B and 7C). Intriguingly, V10, which
features a truncated BG loop, exhibited marked lower affinities for the N2, I3 and L4 peptides than the wt Fyn SH2
domain. Compared with V17 that is also characterized with
a truncated BG loop, V10 contains a bulky Trp residue at the
EF1 position, which would render it to favor p ⫹ 2N specificity rather than p ⫹ 4 even though the p ⫹ 4 binding
pocket is open. Indeed, V10 displayed a greater affinity for
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the N2 than L4 peptide. In contrast, V17 preferred L4 to N2
because the variant contains a small Gly residue at the EF1
position (Table I).
DISCUSSION

Despite having the same protein fold, different antibodies
can recognize different antigens. The remarkable ability of
antibodies to recognize a vast array of antigens is dependent,
in a large part, on the versatility of the six hypervariable loops
within the variable domains of antibodies, commonly termed
complementarity determining regions (CDRs) (20). These
loops connect the ␤-strands of the antibody and are different
from one antibody to another.
The principle of antibody-antigen recognition has been exploited in monobodies, antibody mimetics engineered from
modular domains of much smaller size than a typical antibody. For example, the fibronectin type III domain (FN3), a
molecular scaffold containing ⬃100 residues, has been engineered to create novel target-binding variants, including those
that can function as an SH2 domain inhibitor, by modifying the
loops connecting the ␤-strands (21–24).
As shown in this work, the same principle of loop-mediated
ligand recognition applies to the SH2 domain. Specifically, we
showed that the EF and BG loops in the Fyn SH2 domain are
highly adaptable and evolvable. The extreme versatility of the
EF and BG loops afford them the ability to encode the broad
spectrum of specificity found in naturally occurring SH2 domains. That the EF and BG loops of a single SH2 domain may
be evolved to acquire specificities distinct from the parent
domain is remarkable. Indeed, our comprehensive analysis of
29 loop variants selected by different bait peptides led to the
identification of Fyn SH2 mutants that had switched specificity class from p ⫹ 3 to p ⫹ 2 or from p ⫹ 3 to p ⫹ 4.
Furthermore, we demonstrated that the finer specificity and
affinity of a variant is determined by the characteristics of the
selection peptide, suggesting that the EF and BG loops not
only control the major specificity of the SH2 domain but may
also fine-tune specificity and affinity. Although our study was
focused on the Fyn SH2 domain, it is likely that other SH2
domains are also capable of evolving variants with a wide
spectrum of specificity through loop diversification. This
unique property of the EF and BG loops provides an explanation for how different SH2 domains with the same globular
structure may recognize different pY targets in cells.
SH2 variants with tailored specificity may provide a unique
collection of tools with potential applications in research and
cancer therapeutics. Naturally occurring SH2 domains such
as the Fyn SH2 domain can bind to multiple pY targets in the
cell, making it difficult to dissect the functions of specific
SH2-pY pairs. To increase specificity, Yasui et al. developed
pY-clamps by fusing a mutated SH2 domain to an FN3 loop
variant that has evolved the ability to recognize the sequences
flanking the pY site (14). Our work suggests that SH2 variants
with tailored specificity for a given pY site may be evolved
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directly on the SH2 scaffold by EF/BG loop engineering.
These variants would afford a class of pY sensors by which
to dissect tyrosine kinase signaling in vivo. Because the
specificity pocket and the pY-binding pocket are separate
on an SH2 domain (8, 13, 25), we may also be able to create
a panel of SH2 variants with desired specificity and affinity.
It should be noted that an SH2 domain may also select a
p ⫹ 1 residue (26, 27) and in certain cases, residues N-terminal to the pTyr (11) or C-terminal to the p ⫹ 4 site (28),
which may not necessarily involve the EF or BG loop. Nevertheless, it can be envisioned that simultaneous in vitro
evolution of the pTyr-binding pocket and the specificity
pocket in an SH2 domain may yield a new class of SH2
variants with tailored affinity and specificity for research and
potential therapeutic applications.
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